(1) Communicate the results to the child's parent, legal, guardian or legal custodian;
(2) Communicate the results to the director; and
(3) Refer the child for further diagnostic testing, follow-up and management in accordance with the following, as applicable:
(a) A child with abnormal results on the diagnostic test for one or more of the disorders listed in paragraphs (A)(1) to (A)(34) of rule 3701-55-02 of the Administrative Code shall be referred to an appropriate specialist physician who is approved under rule 3701-43-03 of the Administrative Code as a provider for the program for medically handicapped children and is board certified in pediatric endocrinology, medical genetics, or immunology/infectious diseases , or to a cystic fibrosis center approved for the program for medically handicapped children.
(b) A child with abnormal results on the screen for sickle cell disease, Sickle C disease, Sickle Beta Thalassemia, Alpha Thalassemia (major or intermedia), or Beta Thalassemia (major or H disease) shall be referred to a physician who is approved under rule 3701-43-03 of the Administrative Code as a provider for the program for medically handicapped children and is board certified in pediatric hematology.
(c) A child with abnormal results on diagnostic tests for sickle cell and other hemoglobinopathies shall be referred to a state funded Ohio regional sickle cell project for hemoglobin counseling and follow-up.
(B) The physician to whom a child is referred pursuant to paragraph (A) of this rule shall notify the director of results and disposition of the child within thirty days of the referral.
(C) The director may share newborn screening information obtained pursuant to this chapter and from other sources with programs within the department of health and with individuals or entities under grant or contract with the department of health to assist in locating a newborn child, the child's parent, legal guardian, or legal custodian and to otherwise carry out the functions and responsibilities of the director and the department of health.
R.C. 119.032 review dates: 11/27/2013 and 11/15/2018
Promulgated Under: 119.03
Statutory Authority: 3701.501
Rule Amplifies: 3701.501
Prior Effective Dates: 2/15/1999, 3/17/03, 6/15/03, 2/13/09